TRUSTEES OF TUFTS COLLEGE
Patent Owner
Stats
- 216 US PATENTS IN FORCE
- 22 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 216 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 20,063 Total Citation Count
- Jun 08, 1978 Earliest Filing
- 238 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0036,434 PHOTOLUMINESCENT NANOPARTICLES AND THEIR USES IN DETECTION OR QUANTIFICATION OF SINGLET OXYGENAug 01, 17Feb 08, 18[A61K, G01N]
2017/0370,709 Imaging System To Characterize Dynamic Changes In Cell And Particle CharacteristicsJun 08, 16Dec 28, 17[G01N, G02B, G01B]
2017/0333,461 PEPTIDOMIMETIC INHIBITORS OF POST-PROLINE CLEAVING ENZYMESJun 19, 17Nov 23, 17[A61K, C07F, C07D]
2017/0320,040 METHODS AND KITS FOR REMOVING ORGANIC POLLUTANTS FROM A CONTAMINATED SAMPLEMay 05, 17Nov 09, 17[B08B, B09C, B01J, C02F]
2017/0184,578 METHODS FOR DETECTING TARGET ANALYTES AND ENZYMATIC REACTIONSMar 13, 17Jun 29, 17[G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9839646 Small molecule enhancer for dendritic cell cancer vaccinesNov 23, 15Dec 12, 17[A61K, C07F, A61N]
9834616 Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding proteinMar 23, 15Dec 05, 17[A61K, C07K]
9809838 Methods for determining the concentration of an analyte in solutionOct 11, 16Nov 07, 17[C12Q, G01N]
9757400 Peptidomimetic inhibitors of post-proline cleaving enzymesFeb 12, 16Sep 12, 17[A61K, C07F, C07D]
9731052 Methods for stepwise deposition of silk fibroin coatingsMay 06, 15Aug 15, 17[A61K, C09D, A61L]
9691873 Transient devices designed to undergo programmable transformationsSep 21, 12Jun 27, 17[H01L, B82Y, H01Q, G11B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0258,889 COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTSAbandonedApr 20, 17Sep 14, 17[A61K, B82Y]
2017/0246,255 Stable Analogs of Peptide and Polypeptide TherapeuticsAbandonedJul 24, 15Aug 31, 17[A61K]
2017/0173,161 COMPOSITIONS AND METHODS FOR OCULAR DELIVERY OF A THERAPEUTIC AGENTAbandonedSep 28, 16Jun 22, 17[A61K, A61F]
2016/0250,237 SOFT PROTEASE INHIBITORS AND PRO-SOFT FORMS THEREOFAbandonedNov 04, 15Sep 01, 16[A61K]
2016/0032,397 MAST CELL CANCER-ASSOCIATED GERM-LINE RISK MARKERS AND USES THEREOFAbandonedMar 13, 14Feb 04, 16[C12Q]
2016/0000,857 Method of Regulating Glucose Metabolism, and Reagents Related TheretoAbandonedMay 13, 15Jan 07, 16[A61K]
2015/0299,795 CANCER-ASSOCIATED GERM-LINE AND SOMATIC MARKERS AND USES THEREOFAbandonedMay 30, 13Oct 22, 15[C12Q]
2015/0267,187 Designer Ubiquitin Ligases for Regulation of Intracellular Pathogenic ProteinsAbandonedDec 27, 12Sep 24, 15[C12N, C07K]
2015/0202,218 Broad Spectrum Inhibitors of the Post Proline Cleaving Enzymes for Treatment of Hepatitis C Virus InfectionsAbandonedAug 01, 13Jul 23, 15[A61K]
2015/0056,294 METHODS AND COMPOSITIONS FOR PREPARING A SILK MICROSPHEREAbandonedApr 12, 13Feb 26, 15[A61K, C07K]
2014/0379,094 FIBROUS PROTEIN FUSIONS AND USE THEREOF IN THE FORMATION OF ADVANCED ORGANIC/INORGANIC COMPOSITE MATERIALSAbandonedMay 16, 14Dec 25, 14[A61L]
2014/0371,155 NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOFAbandonedJan 24, 14Dec 18, 14[C12N, C07K]
2014/0287,043 COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTSAbandonedApr 23, 12Sep 25, 14[A61K]
2014/0105,978 SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASEAbandonedOct 17, 13Apr 17, 14[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
